Overview


According to FutureWise analysis the market for immunoassay in 2023 is US$ 42.02 billion, and is expected to reach US$ 59.84 billion by 2031 at a CAGR of 4.52%.

The growth in the number of infectious and chronic disease cases, increased awareness among patients pertaining to immunoassays, technological advancements in immunoassay products are some of the important factors responsible for the proliferation of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunoassay Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Immunoassay Market.

According to the research study conducted by FutureWise research analysts, the Immunoassay Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Roche
  • Abbott Laboratories
  • Siemens
  • Danaher
  • Diasorin
  • Sysmex
  • Biomérieux
  • Ortho Clinical Diagnostics
  • Qiagen
  • Thermo Fisher Scientific
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Mindray
  • Perkinelmer

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product and Service

  • Reagents and Kits
    • Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
    • Rapid Test Reagents and Kits
    • Enzyme-linked immunospot ELISPOT Reagents and Kits
    • Western Blot Reagents and Kits
    • Other Reagents and Kits
  • Analyzers
    • By Type
      • Open-ended Systems
      • Closed-ended systems
    • By Purchase Mode
      • Rental Purchase
      • Outright Purchase
  • Software and Services

By Platform

  • Chemiluminescence Immunoassays (CLIAs)
  • Fluorescence Immunoassays (FIAs)
  • Colorimetric Immunoassays (CIs)
  • Radioimmunoassays (RIAs)
  • Other Platforms

By Technology

  • ELISA
    • First-generation
    • Second-generation
    • Third-generation
    • Fourth-generation
  • Rapid Tests
  • Western Blotting
  • ELISPOT
  • Immuno-PCR
  • Other Technologies

By Specimen

  • Blood
  • Saliva
  • Urine
  • Other Specimens

By Application

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Bone and Mineral Disorders
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Toxicology
  • Neonatal Screening
  • Other Applications

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Blood Banks
  • Research and Academic Laboratories
  • Other End Users

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting the market growth

  • To provide with an exhaustive analysis on the Immunoassay Market By Product and Service, By Platform, By Technology, By Specimen, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with the purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Immunoassay Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biotech Companies Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of CNNs
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.  Immunoassay Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Immunoassay Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Reagents and Kits
         1.1. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
         1.2. Rapid Test Reagents and Kits
         1.3. Enzyme-linked immunospot ELISPOT Reagents and Kits
         1.4. Western Blot Reagents and Kits
         1.5. Other Reagents and Kits
        2. Analyzers
         2.1. By Type
          2.1.1. Open-ended Systems
          2.1.2. Closed-ended systems
         2.2. By Purchase Mode
          2.2.1. Rental Purchase
          2.2.2. Outright Purchase
        3. Software and Services

  • 8.   Immunoassay Market, By Platform Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chemiluminescence Immunoassays (CLIAs)
        2. Fluorescence Immunoassays (FIAs)
        3. Colorimetric Immunoassays (CIs)
        4. Radioimmunoassays (RIAs)
        5. Other Platforms

  • 9.   Immunoassay Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. ELISA
         1.1. First-generation
         1.2. Second-generation
         1.3. Third-generation
         1.4. Fourth-generation
        2. Rapid Tests
        3. Western Blotting
        4. ELISPOT
        5. Immuno-PCR
        6. Other Technologies

  • 10.   Immunoassay Market, By Specimen Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood
        2. Saliva
        3. Urine
        4. Other Specimens

  • 11.   Immunoassay Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Infectious Diseases
        2. Endocrinology
        3. Oncology 
        4. Bone and Mineral Disorders
        5. Cardiology
        6. Hematology and Blood Screening
        7. Autoimmune Disorders
        8. Toxicology
        9. Neonatal Screening
        10. Other Applications

  • 12.   Immunoassay Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinical Laboratories
        3. Pharmaceutical and Biotechnology Companies
        4. Contract Research Organizations (CROs)
        5. Blood Banks
        6. Research and Academic Laboratories
        7. Other End Users

  • 13.   North America Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Romania
         2.10. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. Roche
                  1.1. Company Overview
                  1.2. Financial Overview
                  1.3. Strategic Overview
                  1.4. Product Portfolio
                  1.5. SWOT Analysis
         2. Abbott Laboratories
                  2.1. Company Overview
                  2.2. Financial Overview
                  2.3. Strategic Overview
                  2.4. Product Portfolio
                  2.5. SWOT Analysis
         3. Siemens
                  3.1. Company Overview
                  3.2. Financial Overview
                  3.3. Strategic Overview
                  3.4. Product Portfolio
                  3.5. SWOT Analysis
         4. Danaher
                  4.1. Company Overview
                  4.2. Financial Overview
                  4.3. Strategic Overview
                  4.4. Product Portfolio
                  4.5. SWOT Analysis
        5. Diasorin
                  5.1. Company Overview
                  5.2. Financial Overview
                  5.3. Strategic Overview
                  5.4. Product Portfolio
                  5.5. SWOT Analysis
        6. Sysmex
                  6.1. Company Overview
                  6.2. Financial Overview
                  6.3. Strategic Overview
                  6.4. Product Portfolio
                  6.5. SWOT Analysis
        7. Biomérieux
                  7.1. Company Overview
                  7.2. Financial Overview
                  7.3. Strategic Overview
                  7.4. Product Portfolio
                  7.5. SWOT Analysis
        8. Ortho Clinical Diagnostics
                  8.1. Company Overview
                  8.2. Financial Overview
                  8.3. Strategic Overview
                  8.4. Product Portfolio
                  8.5. SWOT Analysis
        9. Qiagen
                  9.1. Company Overview
                  9.2. Financial Overview
                  9.3. Strategic Overview
                  9.4. Product Portfolio
                  9.5. SWOT Analysis
        10. Thermo Fisher Scientific
                  10.1. Company Overview
                  10.2. Financial Overview
                  10.3. Strategic Overview
                  10.4. Product Portfolio
                  10.5. SWOT Analysis
        11. Becton, Dickinson & Company
                  11.1. Company Overview
                  11.2. Financial Overview
                  11.3. Strategic Overview
                  11.4. Product Portfolio
                  11.5. SWOT Analysis
        12. Bio-Rad Laboratories
                  12.1. Company Overview
                  12.2. Financial Overview
                  12.3. Strategic Overview
                  12.4. Product Portfolio
                  12.5. SWOT Analysis
        13. Agilent Technologies
                  13.1. Company Overview
                  13.2. Financial Overview
                  13.3. Strategic Overview
                  13.4. Product Portfolio
                  13.5. SWOT Analysis
        14. Mindray
                  14.1. Company Overview
                  14.2. Financial Overview
                  14.3. Strategic Overview
                  14.4. Product Portfolio
                  14.5. SWOT Analysis
        15. PerkinElmer
                  15.1. Company Overview
                  15.2. Financial Overview
                  15.3. Strategic Overview
                  15.4. Product Portfolio
                  15.5. SWOT Analysis

  • 19.  Pre and Post COVID-19 Impact
    •     1. Positive influence on the healthcare industry
          2. The financial disruption of the manufacturing sector
          3. Impact of COVID-19 on emerging companies
          4. Significant mandates in the healthcare regulations initiated by
              administrations
          5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME key takeaway points for Client
Partner

Our Clients